Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

The now-annual BIOSPAIN partnering conference took place in Barcelona this week. The event attracted the biggest players in the Iberian peninsula’s biotechnology industry and an increasing number of ...

Complex regional pain syndrome (CRPS) is a rare but severe neuropathic pain condition that causes intense, long-lasting pain, often following an injury or surgery. Patients frequently report some of ...

As artificial intelligence (AI) becomes ever more integrated into the world of biotechnology, one of its latest applications is the discovery and design of peptides. This is a rapidly emerging field ...

The month of September was a big one for mergers and acquisitions (M&As) in the biotech industry. There were four billion-dollar acquisitions that were the most notable. The top buyout was Danish ...

As well as being known for its historical beauty and academic excellence, Cambridge has a reputation as a leading biotech hub, forming part of the U.K.’s “Golden Triangle” with Oxford and London. This ...

The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, ...